Searched for
FINGOLIMOD CAPSULES
Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%The markets have a big element of probability. The way things have panned out in the past few weeks, it is very likely that the bulls will ...
- Stocks in news: Jio Financial, Paytm, Axis Bank, Torrent Power, Asian PaintsJio Financial has been added to BSE Allcap and LargeMidcap indices in a major rejig. The changes will be effective from March 18.
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- Stocks in the news: Tata Steel, Sun Pharma, Airtel, Axis Bank, L&T and GlenmarkSun Pharma, Adani Ports, TechM, UPL, Voltas, Varun Beverages, Chola Finance, UPL, Macrotech Developers, Max Healthcare, Kansai Nerolac and ...
- Zydus Cadila gets tentative USFDA nod to market generic sclerosis treatment drugDrug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Fingolimod capsules, used...
- Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod...
- Cadila Healthcare advances over 2% after USFDA nod for sclerosis drugThe stock had scaled its record high of Rs 558 on June 12, 2017 and a 52-week low of Rs 329.95 on December 26, 2016.
- Top stocks in focus on Monday, 17 July 2017Here is a list of top stocks that are likely to be in focus in today's session.
- Glenmark gets tentative nod from USFDA for Fingolimod capsules"Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Fingolimod capsules, 0.5 mg, the generic version of Gile...
- Natco Pharma files new drug applications with USFDAThe company has filed Abbreviated New Drug Applications for Fingolimod, 0.5 mg capsules and Cabazitaxel, 60mg/ 1.5ml injection with the USF...
Load More
